Combined CDK4/6 Inhibition and Radiation: Effects on Cellular Senescence, Cell Cycle Regulation, and Cell Death in Mammary Carcinoma Cells

CDK4/6 inhibitors such as palbociclib, ribociclib and abemaciclib are commonly used in the clinical treatment of HR-positive, HER2-negative metastatic or locally advanced breast cancer. Patients with metastatic disease often receive palliative radiotherapy for symptom control of bone metastases and/...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lisa Quarz, Luitpold V. Distel, Stefanie Corradini, Laura S. Hildebrand
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2026-04-01
Sarja:	Cells
Aiheet:	CDK inhibition senescence apoptosis necrosis cell cycle arrest palbociclib
Linkit:	https://www.mdpi.com/2073-4409/15/8/734
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!